Edwards Lifesciences target price raised to $115 from $110 by RBC
EW•RBC raised its target price for Edwards Lifesciences to $115 from $110.
Related News
Royalty Pharma: JPMorgan raises target price to $74 from $62
RPRX•
Klaviyo, Inc.: Baird raises target price to $28 from $25
KVYO•
FTI Consulting appoints Aurélien Louis senior managing director in transactions practice
FCN•
Molecular Partners to present initial Phase 1/2a data on MP0712 in lung cancer, other solid tumors
MOLN•
PayPal: HSBC raises target price to $55 from $45
PYPL•